A brief memory screening may offer reassurance, but it does not always tell the whole story. Researchers at Boston University Chobanian & Avedisian School of Medicine have found that a more comprehensive, one-hour assessment could help doctors uncover memory and thinking problems that shorter tests sometimes miss, potentially improving the early detection of cognitive impairment and dementia.
The study examined results from 1,858 veterans assessed at a Veterans Affairs memory clinic between 2017 and 2025. Researchers compared the commonly used Montreal Cognitive Assessment (MoCA) with a longer neurobehavioral status exam (NBSE). The differences were striking. Among patients whose MoCA scores fell within the normal range, 40% were subsequently found to have mild cognitive impairment, while nearly 9% were identified as having dementia following the more detailed assessment. The findings suggest that relying on brief screening tests alone could leave significant cognitive problems undetected.
“Shorter, traditional screeners screening tests are still useful, but they can miss some important problems. When someone notices changes in memory or daily life abilities, a longer, more comprehensive one‑hour test can provide a clearer picture and help guide next steps,” explains corresponding author Brandon Frank, PhD, assistant professor of neurology at Boston University Chobanian & Avedisian School of Medicine. The NBSE offers clinicians a broader assessment of cognitive functioning without requiring the lengthy testing sessions associated with a full neuropsychological evaluation.
Beyond identifying memory difficulties, the one-hour examination also revealed emotional health concerns that had previously gone unnoticed. Mood screening incorporated into the NBSE detected new symptoms of depression and anxiety in approximately 30% of patients. These findings highlight the importance of looking beyond memory performance when evaluating cognitive complaints, as emotional and psychological symptoms can also affect thinking, concentration and everyday functioning.
The findings come as healthcare systems prepare for a growing burden of dementia worldwide. The number of people living with dementia from all causes is projected to reach approximately 152.8 million by 2050. Meanwhile, emerging treatments for Alzheimer’s disease, including anti-amyloid monoclonal antibodies, are increasing the need for timely diagnosis and accurate assessment of disease severity. Although comprehensive neuropsychological testing remains valuable, limited access to specialists, lengthy examinations, and delays in written reports can make it difficult for patients to receive prompt evaluations. “Our study found that a one-hour NBSE could help doctors decide if patients need more extensive testing, such as specialised brain scans or full neuropsychological evaluation,” added Frank, who is also a neuropsychologist at VA Boston Healthcare System.
Importantly, the researchers found that the NBSE could be incorporated into routine clinical practice without requiring every patient to attend an extended testing appointment. The assessment proved useful during in-person consultations as well as video and telephone visits, offering greater flexibility for people who face difficulties travelling to specialist clinics. While the one-hour examination is not intended to replace more extensive diagnostic testing, it could provide doctors with a practical way to recognise cognitive and emotional health concerns sooner and determine which patients need further investigation.
More information: Brandon Frank et al, One-Hour Cognitive Battery Supports Disease Staging in Memory Clinic Practice, Neurology Open Access. DOI: 10.1212/WN9.0000000000000195
Journal information: Neurology Open Access Provided by Boston University School of Medicine